These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 8030444

  • 1. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR, Sass DA, Marshall I, Ma YF, Liang H, Jee WS, Epstein S.
    J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
    [Abstract] [Full Text] [Related]

  • 6. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS.
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S.
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C, Schlosberg M, Epstein S, Ismail F, Fallon M, Thomas S.
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S.
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN, Jacobs TW, Buchinsky FJ, Armstrong EC, Li M, Ke HZ, Ma YF, Jee WS, Epstein S.
    Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
    [Abstract] [Full Text] [Related]

  • 12. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S.
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [Abstract] [Full Text] [Related]

  • 13. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats.
    Del Pino-Montes J, Benito GE, Fernández-Salazar MP, Coveñas R, Calvo JJ, Bouillon R, Quesada JM.
    Calcif Tissue Int; 2004 Dec; 75(6):526-32. PubMed ID: 15654497
    [Abstract] [Full Text] [Related]

  • 14. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
    Boiskin I, Epstein S, Ismail F, Fallon MD, Levy W.
    Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
    [Abstract] [Full Text] [Related]

  • 15. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
    Romero DF, Bryer HP, Rucinski B, Isserow JA, Buchinsky FJ, Cvetkovic M, Liu CC, Epstein S.
    Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
    [Abstract] [Full Text] [Related]

  • 16. Rapamycin: a bone sparing immunosuppressant?
    Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
    Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S.
    Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
    [Abstract] [Full Text] [Related]

  • 18. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [Abstract] [Full Text] [Related]

  • 19. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
    Joffe I, Katz I, Sehgal S, Bex F, Kharode Y, Tamasi J, Epstein S.
    Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
    [Abstract] [Full Text] [Related]

  • 20. Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat.
    Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Paynton BV, Jee WS, Hendy GN, Epstein S.
    J Bone Miner Res; 1995 Oct; 10(10):1556-65. PubMed ID: 8686513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.